NavGeneral InfoEmail Print Geography Global Coverage type Global Time period covered 01/1990 - present Data type Modeled data Summary The duration of the diagnosis/treatment phase for the “Chronic myeloid leukemia” group is based on expert opinion on the average length of treatment that patients undergo after the initial diagnosis of CML. Keywords Leukemia Citation Contributors Institute for Health Metrics and Evaluation (IHME) Suggested citation Institute for Health Metrics and Evaluation (IHME). IHME GBD Cancer Duration for the diagnosis/treatment phase for Chronic myeloid leukemia. GHDx Entry last modified on: Nov 6, 2018